Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
OrthoPediatrics Analyst Ratings and Price Targets | NASDAQ:KIDS | Benzinga
OrthoPediatrics Corp has a consensus price target of $38.3 based on the ratings of 10 analysts. The high is $52 issued by BTIG on October 4, 2023. The low is $24 issued by Truist Securities on April 11, 2025. The 3 most-recent analyst ratings were released by Piper Sandler, Needham, and Truist Securities on May 8, 2025, May 8, 2025, and April 11, 2025, respectively. With an average price target of $32 between Piper Sandler, Needham, and Truist Securities, there's an implied 39.43% upside for OrthoPediatrics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Needham
Truist Securities
Lake Street
Citizens Capital Markets
1calculated from analyst ratings
Analyst Ratings for OrthoPediatrics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/08/2025 | Buy Now | 30.72% | Piper Sandler | Matt O'Brien53% | $40 → $30 | Maintains | Overweight | Get Alert |
| 05/08/2025 | Buy Now | 83.01% | Needham | Mike Matson57% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 04/11/2025 | Buy Now | 4.58% | Truist Securities | Richard Newitter74% | $26 → $24 | Maintains | Hold | Get Alert |
| 04/09/2025 | Buy Now | 83.01% | Needham | Mike Matson57% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 04/07/2025 | Buy Now | 61.22% | Lake Street | Ben Haynor37% | → $37 | Initiates | → Buy | Get Alert |
| 03/21/2025 | Buy Now | 117.86% | Citizens Capital Markets | David Turkaly52% | $50 → $50 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/05/2025 | Buy Now | 39.43% | Stifel | Rick Wise74% | $40 → $32 | Maintains | Buy | Get Alert |
| 03/05/2025 | Buy Now | 83.01% | Needham | Mike Matson57% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 01/14/2025 | Buy Now | 83.01% | Needham | Mike Matson57% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 12/18/2024 | Buy Now | 8.93% | Truist Securities | Richard Newitter74% | $28 → $25 | Maintains | Hold | Get Alert |
| 11/08/2024 | Buy Now | 83.01% | Needham | Mike Matson57% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 10/14/2024 | Buy Now | 22% | Truist Securities | Richard Newitter74% | $34 → $28 | Maintains | Hold | Get Alert |
| 09/13/2024 | Buy Now | 48.15% | Truist Securities | Richard Newitter74% | $30 → $34 | Reiterates | Hold → Hold | Get Alert |
| 09/13/2024 | Buy Now | 117.86% | JMP Securities | David Turkaly52% | $50 → $50 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/13/2024 | Buy Now | 83.01% | Needham | Mike Matson57% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2024 | Buy Now | 83.01% | Needham | Mike Matson57% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2024 | Buy Now | 30.72% | Truist Securities | Richard Newitter74% | $35 → $30 | Reiterates | Hold → Hold | Get Alert |
| 07/16/2024 | Buy Now | 52.51% | Truist Securities | Samuel Brodovsky68% | $38 → $35 | Maintains | Hold | Get Alert |
| 05/08/2024 | Buy Now | 65.58% | Truist Securities | Samuel Brodovsky68% | $35 → $38 | Maintains | Hold | Get Alert |
| 05/07/2024 | Buy Now | 117.86% | JMP Securities | David Turkaly52% | $50 → $50 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/07/2024 | Buy Now | 83.01% | Needham | Mike Matson57% | $37 → $42 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 61.22% | Needham | Mike Matson57% | $37 → $37 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | Buy Now | 74.29% | Piper Sandler | Matt O'Brien53% | → $40 | Reiterates | Overweight → Overweight | Get Alert |
| 03/08/2024 | Buy Now | 39.43% | Truist Securities | Samuel Brodovsky68% | $31 → $32 | Maintains | Hold | Get Alert |
| 03/07/2024 | Buy Now | 61.22% | Needham | Mike Matson57% | $37 → $37 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | Buy Now | 117.86% | JMP Securities | David Turkaly52% | $50 → $50 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/07/2024 | Buy Now | 48.15% | Stifel | Rick Wise74% | $32 → $34 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | 35.08% | Truist Securities | Kaila Krum70% | $39 → $31 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2023 | Buy Now | 69.93% | Truist Securities | Richard Newitter74% | $35 → $39 | Maintains | Buy | Get Alert |
| 12/07/2023 | Buy Now | 117.86% | JMP Securities | David Turkaly52% | $60 → $50 | Maintains | Market Outperform | Get Alert |
| 11/08/2023 | Buy Now | 52.51% | Truist Securities | Richard Newitter74% | $31 → $35 | Maintains | Buy | Get Alert |
| 11/07/2023 | Buy Now | 61.22% | Needham | Mike Matson57% | $55 → $37 | Maintains | Buy | Get Alert |
| 10/04/2023 | Buy Now | 126.58% | BTIG | Ryan Zimmerman71% | $59 → $52 | Maintains | Buy | Get Alert |
| 09/01/2023 | Buy Now | 161.44% | JMP Securities | David Turkaly52% | → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/02/2023 | Buy Now | 122.22% | Truist Securities | Richard Newitter74% | $57 → $51 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | 161.44% | JMP Securities | David Turkaly52% | → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/01/2023 | Buy Now | 139.65% | Needham | Mike Matson57% | → $55 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2023 | Buy Now | 139.65% | Needham | Mike Matson57% | $51 → $55 | Maintains | Buy | Get Alert |
| 05/02/2023 | Buy Now | 161.44% | JMP Securities | David Turkaly52% | → $60 | Reiterates | → Market Outperform | Get Alert |
| 04/17/2023 | Buy Now | 122.22% | Needham | Mike Matson57% | → $51 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 148.37% | Truist Securities | Richard Newitter74% | $53 → $57 | Maintains | Buy | Get Alert |
| 03/01/2023 | Buy Now | 122.22% | Needham | Mike Matson57% | $50 → $51 | Maintains | Buy | Get Alert |
| 01/31/2023 | Buy Now | 144.01% | Truist Securities | Richard Newitter74% | $47 → $56 | Maintains | Buy | Get Alert |
| 01/10/2023 | Buy Now | 117.86% | Stifel | Rick Wise74% | $52 → $50 | Maintains | Buy | Get Alert |
| 11/02/2022 | Buy Now | 161.44% | JMP Securities | David Turkaly52% | $70 → $60 | Maintains | Market Outperform | Get Alert |
| 11/01/2022 | Buy Now | 117.86% | Needham | Mike Matson57% | $59 → $50 | Maintains | Buy | Get Alert |
| 10/17/2022 | Buy Now | 126.58% | Truist Securities | Kaila Krum70% | $66 → $52 | Maintains | Buy | Get Alert |
| 08/05/2022 | Buy Now | 187.58% | Truist Securities | Kaila Krum70% | $51 → $66 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | 165.8% | BTIG | Ryan Zimmerman71% | $65 → $61 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | 117.86% | Stifel | Rick Wise74% | $57 → $50 | Maintains | Buy | Get Alert |
FAQ
What is the target price for OrthoPediatrics (KIDS) stock?
The latest price target for OrthoPediatrics (NASDAQ:KIDS) was reported by Piper Sandler on May 8, 2025. The analyst firm set a price target for $30.00 expecting KIDS to rise to within 12 months (a possible 30.72% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for OrthoPediatrics (KIDS)?
The latest analyst rating for OrthoPediatrics (NASDAQ:KIDS) was provided by Piper Sandler, and OrthoPediatrics maintained their overweight rating.
When was the last upgrade for OrthoPediatrics (KIDS)?
There is no last upgrade for OrthoPediatrics
When was the last downgrade for OrthoPediatrics (KIDS)?
The last downgrade for OrthoPediatrics Corp happened on January 25, 2024 when Truist Securities changed their price target from $39 to $31 for OrthoPediatrics Corp.
When is the next analyst rating going to be posted or updated for OrthoPediatrics (KIDS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OrthoPediatrics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OrthoPediatrics was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.
Is the Analyst Rating OrthoPediatrics (KIDS) correct?
While ratings are subjective and will change, the latest OrthoPediatrics (KIDS) rating was a maintained with a price target of $40.00 to $30.00. The current price OrthoPediatrics (KIDS) is trading at is $22.95, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
